Brighter Outcomes
Intelligent neural interfaces designed for precision therapy and limitless possibility.
Built on Science
Elastro is a clinical stage human technology company that combines next generation neural implants with responsible machine intelligence to address the neurological conditions of our time
Patients First
Elastro is poised to revolutionize the treatment of neurological conditions like epilepsy, Parkinson’s Disease, OCD and more, with the potential to offer drug-free solutions to diseases like addiction, depression and chronic pain
Elastro’s core product combines our Intelligent Neural System (INS) implant with our proprietary machine intelligence. Together, they work with the body’s natural signaling through the nervous system to unlock new possibilities for treatment of neurological conditions
Evolving the
Standard of Care
Elastro’s neural implants build on the foundations of deep brain stimulation and responsive neurostimulation but move far beyond them
Packed with Possibility
Unlike rigid, low-resolution probes that engage limited areas of the brain, Elastro’s unique neural ribbon is soft, flexible, and densely packed with electrodes
Self-Learning
Breakthrough
Synchronized with our machine intelligence, our implants become bi-directional communicators with thousands of neurons, thus enabling precise and responsive electrical signaling wherever needed
Greater Reach,
Greater Precision
Through groundbreaking advances in material design and manufacturing, our neural implants reach throughout the brain, with greater neuron connectivity and greater safety than similar devices
Built to Move with
the Brain
Our interfaces conform to the brain’s natural movement, minimize tissue damage, and deliver precise sensing and stimulation in deep regions that surface-level brain-computer interfaces (BCI) can’t reach
Once engaged, Elastro can diagnose and treat neurological conditions in real-time
"Elastro creates intelligent, adaptive, tissue-like neuromodulators that merge AI with flexible devices to seamlessly communicate with the nervous system. Our vision extends beyond treating neurological disorders — to re-engineer the interface between biology and technology for the future of human health."
Jia Liu, PhD
Assistant Professor
School of Engineering and Applied Sciences, Harvard University
Tomorrow’s Standard
Elastro’s ability to engage neural circuits at scale will create new opportunities for personalized diagnoses, functional restoration, and maximization of human capability.
“Elastro will treat neurological diseases with unprecedented precision and adaptability, without compromising safety. Our platform jumps several orders of magnitude to bring patients faster and more effective outcomes, fewer hospitalizations, and completely new treatment options.”
Mark Richardson, MD, PhD
Director of Functional Neurosurgery Innovation for Mass General Brigham
Professor of Neurosurgery at Harvard Medical School
Human Centered
Our founders include scientists, engineers, and neurosurgeons working at the forefront of device implementation and existing disease treatments